Performance measures | Systemic Performance | Practice Performance |
---|---|---|
Process data | ||
• Reproductive review and care plan instigated | Yes | Yes |
• Care pathway activation | Yes | Yes |
• Initiation of folic acid 5 mg | Yes | Yes |
• Contraception advise given | Yes | Yes |
• Instigated on contraception | Yes | Yes |
• HbA1c testing and results | Yes | Yes |
Pre-pregnancy care targets | ||
• HbA1c ≤ 48 mmol/mol (6.5%) | Yes | No |
• Prescription of 5 mg folic acid pre-pregnancy | Yes | No |
• Cessation of potentially teratogenic therapies | Yes | No |
Pregnancy outcomes | ||
• Neonatal hypoglycaemia | Yes | No |
• Macrosomia (birth weight > 4.5 kg) | Yes | No |
• Shoulder dystocia | Yes | No |
• Caesarean section incidence | Yes | No |
• Neonatal intensive care admissions | Yes | No |
• Postnatal length of stay | Yes | No |
• Any other adverse outcomes | Yes | No |